Mercy Bioanalytics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd Ste 415, Natick, Massac...Website
www.mercybio.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Mercy Bioanalytics
Mercy BioAnalytics, Inc. is a biotechnology company committed to reducing suffering and saving lives through the early detection of cancer. Using nanoparticles that are extraordinarily abundant in blood and carry information about their parent cell known as extracellular vesicles, or EVs the company has developed an approach that is showing tremendous promise in detecting early-stage cancer, when it is most treatable. The company's initial focus is on early detection of difficult-to-treat cancers, such as ovarian and lung, which today are often found too late to save lives.Explore more
Mercy Bioanalytics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mercy Bioanalytics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Mercy Bioanalytics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Mercy Bioanalytics has new funding data
Check out if Mercy Bioanalytics is spiking on competitors!
Mercy Bioanalytics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Mercy Bioanalytics launches new products
Earning: See what the market has to say on Mercy Bioanalytics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Mercy Bioanalytics
Click to see if Mercy Bioanalytics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Mercy Bioanalytics
Compare insights from companies similar to Mercy Bioanalytics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$22.2M
51-200
Private
$10M
2015
AD
Alicia DillardAssociate Clinical Laboratory Director and Molecular Pathologist
Company Profile Activity
Activity Insights
Mercy Bioanalytics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mercy Bioanalytics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mercy Bioanalytics.
Mercy Bioanalytics financials insights
Gather financial insights about Mercy Bioanalytics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$41M
2025
Series B
$59M
Mercy Bioanalytics Tech Stack
A closer look at the technologies used by Mercy Bioanalytics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Funding
Funding
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mercy Bioanalytics
Sign Up For FreeTo access detailed company insights
Mercy BioAnalytics, Inc. is a biotechnology company committed to reducing suffering and saving lives through the early detection of cancer. Using nanoparticles that are extraordinarily abundant in blood and carry information about their parent cell known as extracellular vesicles, or EVs the company has developed an approach that is showing tremend... Read More
